Categorynews

Insights on the Mice Model Global Market to 2026 – Featuring ENVIGO, Genoway and Harbour Biomed Among Others – ResearchAndMarkets.com

November 15, 2021 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Mice Model Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering.

The global mice model market is expected to register a CAGR of 6.8% over the forecast period, 2021-2026.

Companies Mentioned

  • Allentown, LLC
  • Charles River Laboratories International Inc.
  • ENVIGO
  • Genoway
  • Harbour Biomed
  • Horizon Discovery Group PLC (Sage Labs Inc.)
  • Ingenious Targeting Laboratory
  • Janvier Labs
  • Ozgene Pty Ltd.
  • PolyGene
  • Taconic Biosciences Inc.
  • The Andersons, Inc
  • The Jackson Laboratory
  • Trans Genic Inc.

Key Market Trends

Oncology Segment l is Expected to Hold the Significant Market Share Over the Forecast Period

By application by oncology, the segment is expected to hold a significant market share. The major factor propelling the growth of the segment is the rising burden of cancer coupled with the increasing adoption of mice models in various oncology-related drug and vaccine development research. For instance, in August 2020, researchers in the meeting of the American Chemical Society reported that they are developing a new type of immunotherapy for triple-negative breast cancer. The researchers evaluated this therapy in mice models and concluded that it has dramatically extended the survival in triple-negative breast cancer in the mouse.

The Institute of Cancer Research, London stated that mice can be easily genetically altered to allow the study of the genetic causes of cancer and reproduce tumor types that naturally occur in humans for this they have been incorporating mice models in their pre-clinical trials for years. In 2017, 2018. And in 2019 ICR reported the use of 26,320, 23,525, and 25,771 mice in pre-clinical oncology testing. These mouse models are expected to revolutionize drug discovery research, such as the development and verification of various cancer therapies including cancer immunotherapy. Thus, the technological developments and funding by the major players to incorporate mice models in various stages of cancer treatment and diagnostic discoveries will boost the market growth.

North America is Expected to Dominate the Market Over the Forecast Period

Regionally, North America is expected to dominate the mice model market. The concentration of key players in the mice model market is the highest in the North American region. Additionally, the rising number of investments by the government for the development of innovations in mice models is spurring market growth.

For instance, The National Institute on Drug Abuse, United States has awarded an assistant professor at The Jackson Laboratory (JAX), an exploratory grant of USD 212,500, to identify genetic pathways involved in addiction behaviors using genome editing in mice models. Under the grant, the researchers will generate five new mice models with variation in Cyfip2 using CRISPR/Cas9 gene-editing technology.

In addition, market players are also focusing on market development strategies in order to increase their market share in the region. In April 2019, LabCorp and Envigo reported that LabCorp’s Covance Drug Development segment will acquire Envigo’s nonclinical research services business and Envigo’s Research Models Services business will acquire the Covance Research Products business.

Also, in November 2019, Envigo announced an agreement to acquire the assets of the business unit of Horizon Discovery Group plc to combine Horizon transgenic model generation and contract breeding expertise with Envigo operational and commercial capabilities. This acquisition will boost the United State market with new products and services of mice models. All these developments are expected to increase the CAGR of the region during the forecasted period.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Innovation in Mice Models

4.2.2 Rising Demand for Personalized Medicine

4.2.3 Growing Pipeline of Pharmaceutical and Biopharmaceutical Companies

4.3 Market Restraints

4.3.1 Alternatives to Animal Testing

4.3.2 Regulations for the Ethical Use of Animals

4.4 Porter’s Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Type

5.2 By Service

5.3 By Technology

5.4 By Application

5.5 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/hzlq3r

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900